Latest News
Oncopeptides plans EMA filing to broaden Pepaxti indication
11 May 2026 - Oncopeptides AB (STO:ONCO), a Swedish biotech company focused on difficult-to-treat cancers, said on Monday that it intends to submit a Type II variation application to the European Medicines Agency (EMA) to expand the indication for Pe...
GSK partners with SBP Group to accelerate China launch of bepirovirsen
11 May 2026 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) announced on Monday that it has entered an exclusive strategic collaboration with Sino Biopharmaceutical Limited through subsidiary Chia Tai Tianqing Pharmaceutical Group Co, Ltd to supp...
Poolbeg Pharma secures Canadian patent grant for POLB 001
11 May 2026 - Biopharmaceutical company Poolbeg Pharma plc (AIM: POLB) disclosed on Monday that it has received formal notification that the Canadian patent office has granted its patent application covering POLB 001 for the prevention of cancer immu...
Abingdon Health supports UK launch of LVOne stroke triage test
11 May 2026 - Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF) reported on Monday that its customer UpFront Diagnostics has commercially launched the LVOne stroke triage blood test in the UK following UKCA marking and deployment with the London Ambulan...
4basebio introduces enzymatic ssDNA platform for gene editing applications
11 May 2026 - Cambridge-based biotechnology company 4basebio PLC (AIM: 4BB) announced on Monday that it has launched a high-capacity single-stranded DNA (ssDNA) platform designed to support the development of next-generation genetic therapies, includ...